activity
20182021
most citedMutations on COVID-19 diagnostic targets

7 citations · 24 across the 10 of their papers we have counts for

collaborators

12 papers

q-bio.BM20213 cited

Emerging vaccine-breakthrough SARS-CoV-2 variants

Rui Wang, Jiahui Chen, Yuta Hozumi +2

The recent global surge in COVID-19 infections has been fueled by new SARS-CoV-2 variants, namely Alpha, Beta, Gamma, Delta, etc. The molecular mechanism underlying such surge is e…

q-bio.QM2020

UMAP-assisted -means clustering of large-scale SARS-CoV-2 mutation datasets

Yuta Hozumi, Rui Wang, Changchuan Yin +1

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a worldwide devastating effect. The understanding of evolution and tr…

q-bio.OT2020

Inverted repeats in coronavirus SARS-CoV-2 genome and implications in evolution

Changchuan Yin, Stephen S. -T. Yau

The coronavirus disease (COVID-19) pandemic, caused by the coronavirus SARS-CoV-2, has caused 60 millions of infections and 1.38 millions of fatalities. Genomic analysis of SARS-Co…

q-bio.GN2020

Host immune response driving SARS-CoV-2 evolution

Rui Wang, Yuta Hozumi, Yong-Hui Zheng +2

The transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of paramount importance to the controlling and combating of coronavirus disease 2…

q-bio.GN20201 cited

Characterizing SARS-CoV-2 mutations in the United States

Rui Wang, Jiahui Chen, Kaifu Gao +3

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been mutating since it was first sequenced in early January 2020. The genetic variants have developed into a fe…

q-bio.PE20205 cited

Decoding asymptomatic COVID-19 infection and transmission

Rui Wang, Yuta Hozumi, Changchuan Yin +1

Coronavirus disease 2019 (COVID-19) is a continuously devastating public health and the world economy. One of the major challenges in controlling the COVID-19 outbreak is its asymp…